1/95
Looks like no tags are added yet.
Holoprosencephaly
Incomplete division of embryonic forebrain (prosencephalon) into lateral hemispheres
- 1:250 conceptions/1:10,00 live births —> one of the most common embryonic abnormalities, but most are lethal in utero
- Assoacted with dysmoprphic features related to laterality: cylopia, probisoicus, hypertelorism, SCMI (a tooth thing?)
“Face preditcs the brain” : mental retardaiton, seixures, pituitary insufficney, FTT
Holoprosencephaly Eitology
- 90% genetic
Half are Chrsome Abnormalities: OVERWHELMINGLY Trisomy 13 (Patau)
Half are Monogenic disorders: Mutations in SHH (Non-syndromic) autosomal domaint
HPE and Patau syndrome
***MOST COMMON CAUSE OF HPE ACROSS ALL GENETIC CAUSES***
HPE occurs with:
Facial clefting
****POLYDACTYLY***
CHD
PKD
Omphalocele
Severe mental retardation
3% Survival at 1 Year
Recurrence risk: 1%
HPE and SMith-Lemli-Opitiz Syndrome
HPE with:
Cleft palate
CHD,
GU anomaly (usually men with genital ambiguity)
low set ears
****2-3 Toe Syndactyly*****
Variable intellectual disability, grow retardation and life span
Etiology: 7-Dehydrocholestrol Reductase (7-DHCR) Gene Mutation
Recurrence Risk: 25% (Autosomal Recessive)
HPE and Sonic Hedhog (SHH) Pathway gene mutation
HPE is isolated and with variable mental retardation
Etiology: SHH gene mutation
Recurrence risk: 50% for affected Indvidual (Autosomal Dominant)
→***minimal recurrence risk if parent unaffected, but variable expressivity so test parents***
HPE and Genetic Testing
We can suspect from ultra sound but need empiric testing
Karyotype: for Trisomy 13
CMA: for pathogenic CNVs
Gene Testing:
SHH (Sonic hedgehog) if ISOLATED
Parents need testing as well: variable expressivity in a SHH mutation carrier
Smith-Lemi-Optiz and/or other conditions if SYNDROMIC
HPE Outcomes
There will ALWAYs be some degree of mental retardation: but can be VERY variable
If there is a Cyclopia/probiscis: Always Lethal
If Trisomy 13: 5-8% survival 12months
Lissencephaly
The absence or significant reduction of the normal folds and grooves (gyri and sulci) on the surface of the brain:
“Smooth Brain” with lower surface area for cortical neurons
a “inside out” cortex (layers on the outside are stuck on the inside)
Can be “diffuse”(entire brain) or “patchy” (cobblestone)
Found via MRI either:
Prenatal: can by viewed at >24 weeks gestation - at this point devleoping brains gain the ‘gyration’
At birth
Invariable will cause some degree of Intellectual Disability
Important Associated syndromes:
Miller-Dieker Syndrome
Muscle-Eye-Brain Disease
Miller-Dieker Syndrome
****#1 Cause of Lissencephaly****
Microdeletion syndrome in 17p13.3: ~ 50 genes in region
Lis1→ Lissencephaly
YWHAE→ greater intellectual severity
Other genes→ Dysmorphic features (
Midline vertical forehead crease/furrowing
Facial: depressed nasal bride, micrognathia
Cardiac/GI Anomalies
Essentially Always De Novo (not inherited): low reproductive fitness due to severe MR
Prognosis:
severe growth and Mental retardation,
life expectancy <2 years
Muscle-Eye-Brain Diseases
A common cause of lissencephaly (Brain) that are a part of syndromic features that include ophthalmalgia abnormalities (Eye) and progressive muscular dystrophy (Muscle)
3 Types from most to least severe
*POMT1 Gene (Walker-Warburg)*
Fukutin Gene (Fujuyama CMD)
POMGT1 Gene (Finnish MEB disease
All have varying degrees of
Progressive muscular dystrophy (muscle disease): High Creatine Kinase with a progressive muscle weakness
Micorpathalmia: small eye (Eye disease)
Cobblestone Lissencephaly (Brain disease)
Prognosis: Blindness and progressive weakness that leads to death (usually from resipatory failure)
Inheritance: All Autosomal Recessive
Walker-Warburg Syndrome
One of the 3 Muscle-Eye-Brain Diseases that are associated with Lissencephaly → of the 3 LESS severe (but its still bad)
Features
Brain: COBBLESTONE Lissencephaly
Eye: Microphthalmia (small eye) and other ophthalmologic abnormities - Retinal malformation
Muscle: Congenital Muscular Dystrophy → increased CK
Prognosis: very poor → death in infancy or early childhood
Hydrocephalus
Increase in Cerebral Spinal fluid in the cranium
Incidence 1:500 → Fairly common
Mostly NON-GENETIC causes (blockages in ‘flow’): potentially normal IQ if treated, low recurrence risk
But, there still are genetic causes: most important it
L1-CAM Hydrocephalus or “X-Linked Recessive Hydrocephalus”
L1CAM Congenital Hydrocephalus
Hydrocephalus that is cause by a single gene mutation in the L1CAM gene that is on the X-chromosome
Features : MALES ONLY
Hydrocephalus WITH stenosis of Aqueduct of Sylvius( exit for CFS from the ventricular system)
***Intellectual disability despite treatment***
Spasticity of the muscles
Adducted thumbs: thumb cannot be straightened
Need to check in L1CAM gene in mom if:
History of unexplained son hydrocephalus
A Son with a adducted thumbs
Dandy-Walker Malformation
a specific developmental malformation of the posterior fossa (back of the brain)
Hypoplasia of the cerebellar vermis
Cystic dilatation of the fourth ventricle
Enlargement of the posterior fossa
Causes
Cerebellar dysfunction: Ataxia, Nystagmus
Seizures, Apnea, Hypotonia
Increased risk for Mental Retardation but normal IQ possible (>50%)
Meckel Gruber syndrome
Genes :MKS1 – TMEM67 – CEP290 – CC2D2A – RPGRIP1L
OVERLAP WITH JOUBERT SYNDROME
Ciliopathy
Inheritance
Autosomal Recessive
Clinical Features
Lethal
Classic triad of
Brain malformation:
***Occipital Encephalocele***(hole in skull)
Dandy-Walker Malformation (both posterior fossa abnormalities)
Bilateral Cystic Kidneys → Potters Sequence
Postaxial Polydactyl
Differential Diagnosis:
Joubert Syndrome: both ciliopathies
Bardet-Biedl Syndrome: polydactyl and renal disease shared
Trisomy 13: polydactyl, CNS anomalies, cystic kidneys shared
Testing:
CMA - excluded chromsal disorders
Multigene ciliopathy panel
prenatal exome if CMA is nromal depsite utlrasound findings
Hydranencephaly
During devleopment, when brain structures do not get proper vascualrazation, they will not delvope and simply liquify: this iswhat happens (holy shit)
Clinical: prentatl liquication necrosis of coritcal sturcutres (instead of a brain/coritcal strucutres there is just fluid)
Etiology: pirmality vascualr disrution (never a fetal gene error)
Recurrence Risk: Very Low- tends not to be genetic, but RARE cases of Autosomal Recessive families
Joubert Syndrome
A typcially NON-Lethal (unlike Meckel-Gruber) ciliopathy that affects brain, kidney, and liver
Brain (DISTINCT):
***Molar Tooth Sign: pocket in the midline posterior brain → very distinct MRI sign***
Mental retardation, hypotonia, seizures, ataxia, nystagmus (irregular eye movements), ABNROMAL BREAHTING
Kidney/Liver:
Hepatic fibrosis
Nephronophthisis
Dysmorphic Facial Features
tall forehead, upturned nose, open mouth
Etiology: Recessive and X-Linked
A 32yo G1P) Femal with gestational diabetes has a level II fetal ultrasound at 22 weeks gestion which shows ventricular enlargement.
Which is the possible diagnosis?
Hydranencephaly
Hydrocephaly
Holoprosencephaly
Lissencephaly
Any of the above
Any of the above
A 32yo G1P) Femal with gestational diabetes has a level II fetal ultrasound at 22 weeks gestion which shows ventricular enlargement. AND
She reports no medication or drug use asiade from prenatal vitamins, there is no family history of hydrocephalus and she had a normal ‘triple screen’.
Fetal Skull, XRAY, Head CTScan, Brain MRI, AMinocetisis or Chrsome Microarray?
Fetal Brain MRI
A 32yo G1P) Femal with gestational diabetes has a level II fetal ultrasound at 22 weeks gestion which shows ventricular enlargement. AND
She reports no medication or drug use asiade from prenatal vitamins, there is no family history of hydrocephalus and she had a normal ‘triple screen’.
On tkaing a family history the mother has leanring diablties and didn;t graduate high school. When she smiles you notice she has one centeral maxillary incisor.
This suggest her recurrence risk in the futre pregencies is closest to:
0%
1%
25%
up to 50%
100%
Up to 50%: since she has (ID + Incisor) suggest a mild form of HPE, which does not indicate syndromic HPE. So, she probably has the form from SHH pathway mutations ,which are Autosomal Dominant —> thus, 50% recurrence to have another child with HPE
Developmental Disalbites
Structurally normal brain (no Malformation), but does not function as normal
CNS disfunction
Developmental delays
Intellectual disability
Autism
Stuttering
Hearing/Visual impairment
ADD/ADHD
Cerebral Palsy
Seizures
Autism Spectrum Disorder
reorganization of multiple disorders under one
Criteria
Deficits in social communication and social interaction
Restricted, repetitive patterns of behavior, interests or activities
Onset of symptoms in infancy/early childhood
symptoms limit and impair everyday functioning
Autism Screening: Excluding contributing Conditions
Lead Intoxication → Check Lead Levels in blood/CSF
Hypothyroidism → Check TSH levels
Deafness/Hearing loss → Audiology Evaluation
Extreme impovershed Environment
Prenatal Exposures → Toxins, Infections, Premature, Brain trauma
Autism Incidence
Male: Female Raito of 4:1 → MORE MEN THAN WOMEN
Autism Heritability:
Familial Autism recurrence rate:
5-10% if 1 child affected
25% if 2 Children affected
Heritability Factor (Genetic Cause): 37-90%
Heterogenous Genetic Autism Associated Syndromed
Can be single gene, Mendelian or Chromosomal
Single gene
Fragile X (#1 cause)
Rett Syndrome
Tuberous Scerlrosis
Neurofibromatosis Type !
PTEN Syndrome
Smith-Lemli-Optiz
Kallman Syndrome
Soto syndrome
IEM → PKU
Chromsomal
Down Syndrome
Klnifleter
Microdeltion
Prader willi
Angelman
Smith-Magenis
Digeorge
Williams
Common single Gene Autism-related Disorder
Fragile X (FMR1 gene, XL): 2%
Ret Syndrome (MECP2 Gene, XLD): 1%
PTEN Related (PTEN gene, AD): 1% (15% if macrocephaly)
Tuberous Sclerosis (TSC1-4 gene, AD): 1% (5-15% if epilepsy)
Neurofibromatosis Type 1 (NF1 gene, AD): 1%
Fragile X Syndrome: Overview
#1 Genetic Cause of Moderate MALE Mental Retardation
Caused by CGG repeats on the FMR1 gene located on the X-chromosome
CGG repeats “expand” during female meiosis → increased of repeats in the EGGS
1:3,600 Males
Premutation carriers: 1:260 female and 1:800 males
Fragile X: Complex Screening
Fragile X Syndrome: Features
Typical Dysmorphgoly
Long face
Prominent ears
**Macrocephaly**
High forehead
Macroorchidism
Mental Retardation
Males: 90% severe, 10% Borderline MR IQ
Female: 50% normal IQ, 25% borderline MR, 25% Severe
Behavior
80% Autism
>90% ADHD
Seizures: 25-40%
Developmental Dealy
Fragile X: Premutation Carriers
Premutation carriers are at risk of
Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) : Parkinson-like condition,
33% of male carriers,
6% of female carriers;
age of onset after 50yo
Primary Ovarian Insufficiency (FXPOI):
25% of premutation carriers,
early menopause by age of 40yo
Fragile X: Repeats
Higher risk for expansion if inherited from MOM rather than DAD
“CGG” Trinucleotide repeats in FMR1
6-40 repeats: Normal gene expression
45-54 repeats: “Grey Zone” unaffected parent can have expansion into premutation range (not full mutation range)
60-200 repeats: Premutation; can expand, increased FMR1 expression
>200 repeats: Full mutation, No FMR1 expression
Fragile X: Interruptions
“AGG” Interruptions: can lower the chance for expansion
More AGG interruptions= Decreased expansion risk
MOST IMPACTFUL for “Grey zone” Women → testing women for AGG interruptions as well as CGG repeats can refine risk estimate
Aicardi Syndrome
Gene: CAUSE UNKNWON
ONLY OCCURS IN 46,XX Female
Inheritance
***X-LINKED RECESSIVE****
COMPLETLE DE NOVO
Clinical Features
CNS
*****Agensis of the Corpus Callosum***** (hallmark)
***SEIZURES*** (first few months of life)
INFANTILE SPASS
Eye
****Chorioretinal Lacunae****(absent retinal pigment epithelium)
Rett Syndrome
MECP2 mutation - important for methylation control
X Linked Dominant: Female Only (Lethal in all XY Males) → ALWAYS DE NOVO (never family hx of Rett)
Typical Signs and Symptoms
Normal Development 6-18 months
Regression 1-4yo
Acquired Microcephaly: head growth slows but body keeps growing
Mental Retardation,
***Seizures***,
Ataxia,
Repetitive Hand movement,
Apnea
Stabilization Period 2-10yo
slight increased awareness + minimal verbal communication
Later Motor Deterioration after 10yo
Loss of mobility, full physical disability → Early Death
PTEN Mutations
***Autism with Macrocephaly***
Autosomal Dominant mutations in PTEN Gene → 17% of Macrocephalic Autistic Children have PTEN mutation
PTEN mutations overlap with Cancer Syndromes:
Cowden Syndrome:
Increased Breast, Thyroid, Kidney, Colorectal, Endormtial Cancer
Palmoplantar Keratosis
Trichilemmomas
Oral Fibroams
Bannayan-Riley-Ruvalcaba syndrome:
Mental Retardation
Hamartomas GI polyps
Penil Lentrigines (spots on end of pen island)
***ALL PATIENTS WITH AUTISM AND MACROCEPHALY SHOULD GET TESTED INTHE PTEN GENE***
Tuberous Sclerosis: Overview
****20-50% Have Autism****
Autosomal Dominant TS Gene Mutation (4 Genes)
75% De Novo
25% Inherited
TS gene sequencing detects most mutations
Classic Clinical Triad
Adenoma Sebaceum (50-80%)
Epilepsy (75%)
Mental Retardation (50%)
Tuberous Sclerosis: Major Diagnostic Features
Need >1 feature to make a diagnosis (different from the common clinical triad → non-specific features (epilepsy, MR, Autism, etc.)
Heart
****Congenital Rhabdomyoma****
Skin:
“Ash-Leaf” Macules (>3)
Facial Angiofibroma
Periungual Fibroma
Eye
Retinal nodular hamartomas
Lung
Lymphangiomyomatosis
Kidney:
Renal angiomyolipoma
Neurofibromatosis Type 1 (NF1): Overview
***Learning Disability in ~50% (ADHD, AUTISM)***
NORMAL INTELLGENCE
Not increased risk for seziures
Autosomal Dominant Neurofibromin Gene Mutation:
50% De Novo
50% Inherited
NF1 Gene sequencing detects most cases
Neurofibromatosis Type 1 (NF1): Features + Diagnostic criteria
Major Diagnostic Features (Need >1)
***6 or more Cafe-Au-Lait Sports***
2 or more Neurofibromas
2 or more Lisch nodules (Iris Hamartomas → contrast with TS Retina Hamartomas)
Optic Glioma
Axillary or Inguinal Freckling
Osseous Lesions
1st Degree Relative Diagnosed with NF1
Major Morbidities
Large Neurofibroma mass → become malignant
Increased Cancer: Pheochromocytoma
Resistant Hypertension → Renal Artery Stenosis
Learning Disabilities (AUTISM) but NORMAL IQ
Mowat-Wilson Syndrome: overview
ZEB2 Mutation: Important for neural crest migration
Inheritance
ZEB2 gene mutation: Autosomal Dominant
ALWAYS DE NOVO
Clinical Features
***Hirschsprung Disease***
Seizures
Intellectual Disability
Minimal speech
*HAPPY DEMANOR*
*FREQUENT LAUGHTER*
*WIDE-BASED GAIT*
(Often confused with ANGELMAN SYNDROME)
Dysmorphic Facial Features
hypertelorism (eye too close)
Broad Flared eyebrows
Low columella
Prominent, pointed chin
***Uplifted earlobes***
Congenital heart defects
Microcephaly
Treatment: Multidisciplinary
Neuro, Developmental Pediatric, Ophthalmologist, GI, Cadio, PT/OT/ST
HALLMARK: Hirschsprung disease + a characteristic facial appearance (Earlobes or Chin) + severe developmental delay
Rubenstien-Taybi Syndrome
CREBBP mutation: histone activity during embryonic development
Inheritance
Autosomal Dominant
ALWAY DE NOVO
Clinical Features
****BROAD THUMBS AND GREAT TOES*****
Dysmorphic Facial Features
grimacing smile
down slanting palpebral fissures
highly arched eyebrows
long eyelashes
prominent or beaked nose
Developmental/Intellectual Delay: wide variability
Intellectual disability: wide variability - mild-moderate range
Autism (40%)
Birth Defects
Heart
GU
Dysplastic Corpus Callosum
Eye and Ear → issues with hearing and sight
Treatment: Multidisciplinary
Neurology, Development pediatrics, Ophthalmology, Audiology, GI, Cardio, PT/OT/ST
Hallmark: Broad thumbs/great toes + Intellectual Disability
Cornelia de Lange syndrome
Genes: NIPL (60%), RAD21, SMC3, BRD4 mutation (+ HDAC8 and SMC1A)
Inheritance:
Autosomal Dominant (usually)
X-linked for HDAC8 + SMC1A
Mostly De Novo (1% Inherited)
Clinical Features: Wide spectrum - mild cases vs severe are STARK contrast
Dysmorphic Facial Features
****Connected Eyebrows (Synophyrs)****
***Long eyelashes***
short upturned nose
micrognathia
thin upper lip
Severe Fetal Growth Restriction
**Upper Limb Reduction Abnormalities (mild to severe) **
Small hands, short fingers (mild)
****Absent Finger, Hand, or Forearm****
Intellectual Disability (moderate to severe)
Autism*****
Congenital Heart Defects
Hearing Loss
Hallmark: [Synophrys] + [limb defects] + [growth restriction]
Kabuki Syndrome
Genes: KMT2D (70%) and KDM6A (8%)
Inheritance
Autosomal Dominant → KMT2D
X-Linked → KDM6A
ALWAYS DE NOVO
Clinical Features
Dysmorphic Facial Features
***Long Palpebral Fissures***
*Eversion of lower eyelid*
Arched, broad Eyebrows
Large prominent ears
****Persistent Fetal Fingertip Pads****
Congenital Heart Disease
**Coarctation of the Aorta**
Hypotonia + Developmental Delay → Post-Natal Growth Deficiency
Intellectual Disability
Hallmark: Fetal Fingertip Pads + Palpebral Fissures + CHD + Hypotonia/Post-natal growth deficiency
"Kabuki actors have dramatic EYES and wear FINGER PADS."
Developmental Epileptic Encephalopathies
Etiology:
50% genetic cause Whole Exome/Genome sequencing recommended (huge gene heterogeneity, >900 genes associated)
Most common gene SCN1a Mutation associated Dravet Syndrome
Prevalence 1:600-1,000
Clinical Features
Seizures, slowed development and regression, onset infancy or childhood
overlap with many different epileptic syndromic presentations
Dravet Syndrome
Gene: SCN1A (neuron ion channel protein → regulates activity, LOF = overexcitement)
Inheritance
Autosomal Dominant
ALWAYS DE NOVO
Clinical Features
Normal birth and initial development
Infancy (6-12months): Development of PROLONGED FEBRILE SEIZURES
Triggered by Fever, Vaccine (immune response), Hot Baths → high heat
Childhood:
Intellectual disability
Ataxia
Hypotonia
Lifelong:
Epilepsy
Intellectual disability
Gait abnormalities
Increased risk of Sudden Unexpected Death in Epilspey (SUDEP)
Treatment/Management
Neurologist/Epileptologist: molecularly guided anti-epileptic therapy
Avoid sodium channel blockers
[Dravet = Dramatic Fever Seizures]
Chromosomal Autism Associated Disorder
Down Syndrome (Trisomy 21)
Klinefelter Syndrome (47, XXY)
Non-Eponymous Microscopically visible chromosomal Del/Dup/Rearrangements in Individuals
All of these will be apart of workup for suspected Autism Desanges
Recommend chromosome analysis be offered to all individuals with unexplained autistic features
Overall incidence of detectable Microscopic Chromo. abnormalities: 2-4%
Microdeltion Autism Assoacted Syndromes
DiGeorge Syndrome (22q11.2 Deletion)
“CATCH22” :
Cardiac defects (interrupted aortic arch/TOF),
Abnormal facies (boxy nasal tip),
T-Cell immunodeficiency,
Clefting of lip/palate,
Hypocalcemia
Williams syndrome (7q11.23 Deletion):cocktail party
Prader-Wili Syndrome (Paternal 15q11-13 deletion/imprinting): Hungry
Angelman Syndrome (Maternal 15q11-13 deletion/imprinting): happy puppet
Smith-Magenis syndrome (17q11.2 Microdeletion): stuff in ass+ Self injusry disorder
Genetic Evaluation of Autism
Look for Underlying Etiology: Asses for the hallmarks syndromes
Physical exam: including
morphologic Skin Exam (Wood Lamp),
Facial features
RULE OUT other non- genetic casues:
Audiology
Lead and thyroid testing in all,
MRI/EEG as indicated
Based on what you find: Syndrome Specific Genetic Testing if Indicated
PTEN gene testing if macrocephalic,
TS or NF1 testing if neurocutaneous signs
Empiric Genetic Testing if Cause is Unclear
Chromosome microarray analysis and karyotype for all
Fragile X DNA testing for all males and females
Rett syndrome MECP2 gene testing for all females only
Newer ASD Gene Testing
Autism/ID gene panels
Whole Exome/Whole Genome Sequencing (WES/WGS)
Testing Yield: 20-30% will have a GENETIC EXPLINATION
Coffin-Lowry Syndrome
Gene: RPS6KA3
Inheritance
X-Linked DOMIANT
Boys affected
Girls range from unaffected to mildley affect due to x-inactivation
ALWAYS DE NOVO
Clinical Features
***Stimulus-Induced Drop Episodes***
collapse when excited or startled
Hands
Soft, Large, fleshy hand (“puffy”)
Short, tapered fingers
Dysmorphic facial features
Coarsening of facial features
Intellectual disability (moderate to severe)
Pitt-Hopkins Syndrome
Gene: TCF4
Inheritance
Autosomal Dominant
ALWAYS DE NOVO
Clinical Features
****Episodic Hyperventilation/Apena****
Rapid breathing (hyperventilation)
then followed by breath-holding (apena)
Triggered by excitement, anxiety, emotions
**Severe Intellectual disability**
Absent Speech
Severe Constipation
Familial Dysautonomia
Gene: ELP1
Inheritance
Autosomal Recessive
***Founder Mutation: Ashkenazi Jewish Ancestry***
1/30 Ashkenazi Jewish Pop. frequency
Clinical Features
**Decreased (but not fully absent) Pain sensitivity**
Autonomic Dysfunction
Unstable blood pressure
Unstable body temperature
***Recurrent vomiting episodes***
**Absent Tears**
Feeding Issues
Diagnostic Criteria also include:
Absence of fungiform papillae on the tongue
Deep-tendon reflexes
Hallmark: Absent Tears + Autonomic crisis + Insensitivity + Ashkenazi ancestry
DysAUTONOMIA = AUTONOMIC nervous system.
Cockayne Syndrome
Genes: ERCC6 (80%) and ERCC8 (20%) - important for chromosomal breakage repair →
Mutations do not cause cancer b/c cells with that much DNA damage APOTOSIS rather than keep dividing
Inheritance
Autosomal Recessive
Clinical Features
Postnatal growth failure
*short stature*
low weight
***Microcephaly (Progressive)*** → like RETT; head starts normal than stops growing w/ the body
****Progressive Neurodegeneration****
Loss of skills
Intellectual disability
Ataxia/tremor/spasticity
**Hearing Loss**
**Vision Loss**
***Photosensitivity***
BUT NO INCREASED CANCER RISK
Hallmarks: Photosensitivity+ progressive neurodegeneration+ no cancer predisposition
GLI3-Related Pallister–Hall Syndrome (PHS)
Gene: GLI3 (SHH signaling pathway)
Inheritance
Autosomal Dominant
75% Inherited
25% De Novo
VARIABLE EXPRESSIVITY
Clinical Features
***Hypothalamic Hamartoma****
benign congenital mass of neuron cells
can cause:
Adrenal+Pituitary insufficiency / endocrine abnormities
“laughing” seizures
Polydactyl (6 fingers)
Epiglottis abnormalities:
Bifid Epiglottis
Prognosis
HIGHLY VARIABLE: many have nromal lifespan and congtion
Longterm outcomes depdne larelgy on
encorine dysfunction
seizure contro
Sturge-Weber Syndrome
Gene: GNAQ → in the RAS pathway, but not a RASopathy.
A neurocutaneous syndrome
Inheritance
****SPORADIC SOMATIC****
i.e. Mosaicism
Highly variable phenotype
NO INHERITANCE
Clinical Features
****Port-Wine Stain Birthmark****
towards top of face
a “V-1” pattern
***Seizures***
start in infancy
***Leptomeningeal Angioma*** (hallmark brain lesion)
Glaucoma
Range from normal intelligence to severe developmental disability
Hallmark: Port-wine Stain + Leptomeningeal angioma + glaucoma
Stain, Seizures, Somatic Mutation
Cerebral Autosomal Dominant Arteriopathy wit Subcortical Infarct and Leukoencephalopathy (CADASIL)
Gene: NOTCH3 → expressed in vascular smooth muscle
Progressive neurodegenerative w strokes IN ADULTHOOD
Inheritance
Autosomal Dominant
Clinical Features
An ADULT-ONSET progressive neurodegenerative condition
***Migraine with Aura***: 20s-30s yo
****Recurrent Stroke****: 40-50yo
Cognitive Decline:
Executive functioning
Vascular dementia
***MRI Findings: WHITE MATTER HYPERINTENSITIES***
Treatment/Management
No treatments
Hallmark Progression: Migraine w Aura → Recurrent Strokes → Vascular Dementia
Familial Cerebral Cavernous Malformations
Genes: KRIT1(most common), CCM2, PEDCD10 (most severe) → mutations lead to fragile vascular channels that leak/bleed
Inheritance
Autosomal Dominant
Inherited 90%
De Novo 10%
***Incomplete penetrance and variable expressivity*** → within same family vastly different clinical outcomes
“Two Hit Theory: inherit one mutation (hit one) + a Somatic mutation arises (hit two) = Cerebral cavernous malformations (CCMs) develop
Clinical Features
****Seizures***
**Intracranial Hemorrhage**
CCM lesions can bleed easily
Epilepsy
progressive neurologic deficits
Headache
MRI FINDINGS: “Popcorn” Cavernous Malformations
Management
Highly variable prognosis
Some are asymptomatic and unaffected
Others are recurrent hemorrhage, epilepsy and neurologic deficits
antiseizure medication,
surgical resection of lesions
Hallmark: “Caverns look like Popcorns” → Popcorn brain lesions w seizure + hemorrhages
Malignant Hyperthermia
Gene: RYR1 (70%) CACNA1S (less common) → important for calcium regulation in muscles
An Pharmacogenetic disorder that causes muscle hypermetabolism
Inheritance
Autosomal Dominant
low De Novo rate
Clinical Features
Triggered by specific drugs: Volatile Anesthetics or Succinylcholine (Neuromuscular blocker)
Muscle Rigidity
High CO2 levels
***Hyperthermia***
Muscle overactive → leads to quick rise in body temp
Rhabdomyolysis
elevated CK
Treatment
Give Dantrolene
Blocks calcium channels → reverse crisis
Inherited Neurodegenerative Diseases
Conditions that arise in anatomically normal brains w/ normal function
But experience an Earlier than expect and/or MORE SEVERE than expected DECLINE in function
Including
Alzhimers’s Disease
Parkinson’s Disease
Amyotrophic Lateral Sclerosis
Huntington’s Disease
Most Common Neurodegenerative Diease
Alzheimer’s Disease: also most common irreversible cause of dementia
Alzheimer’s Disease: Risk
Age is a MAJOR risk factor
General Population Lifetime risk: 10%
slightly higher in women than in men
By 65yo - cutoff age for “Early Onset” - 1-3%
By 85yo: 20%
By 95yo: 45%
Familial Alzheimer’s Disease (AD)
AD patient’s w/ a (+) fam. history: 10-25%
AD Early Onset patient w/ a (+) fam. history: 60%
*****Lifetime risk for 1st degree relatives of AD patients: 20-25%*****
Alzheimer’s Disease: Clinical features
Progressive impairment of
memory
judgment
decision-making
orientation to physical surroundings and language
Pathological Hallmarks: need to distinguish from other neurodegenerative disease (BUT NOT USED FOR DIAGONASIS DURING THE LIFETIME →only post mortem (cannot take brain biopsies))
Neuronal loss (cortex and hippocampus)
Extracellular amyloid plaques
Intracellular neurofibrillary tangles
NO PROVEN TREATMENTS: But MIND Diet can reduce risk 30-50% over 10 years
Alzheimer’s Disease: Early Onset
Genes: APP, PSEN1, PSEN2
Amyloid Protein Production (APP) and Splicing (PSEN1, PSEN2)
Abnormal Amyloid protein ‘version’ AB:1-42 is what causes AD
Inheritance
Autosomal Dominant
HIGHLY penetrant (PS1 in particular)
Only 5% of Alzheimer’s Disease
Clinical Features
Onset of Alzheimer’s is Before 65yo
PSEN1 mutation: Age of onset *28*-62yo
Alzheimer’s Disease: Late Onset
Genes: ApoE; 3 ‘isoforms’ (Alleles) - E2, E3, E4
Shuttle LDL through the bloodstream
E2 - Reduces risk of AD
E3 - No increased risk of AD
****E4 - Increases risk of AD****
Inheritance
Autosomal Dominant
Clinical Features
Risk for Late Onset AD depends on how many copies of the APOE alleles
APOE4:
No E4 Alleles: 10% risk
1 E4 Allele: 20% risk
2 E4 Allele: 25-35% risk
Each E4 allele shifts age of onset 5-10 years earlier
APOE2
Alleles REDUCE risk (but unknown numbers)
Alzheimer’s Disease: Early Onset - Genetic Testing
Who should be tested for Early Onset AD genes?
Individuals with Early Onset AD (duh)
Individuals with a strong Fam Hx of either: early onset AD OR a clear pattern of Autosomal Dominant Alzheimer disease (vertical transmission, even if it is Late Onset)
caution for presymptomatic testing:
No proven preventive treatments
But, can allow for clinical trial participation or future treatments
Alizhmeris Disease: APOE4 Allele Genotyping
***APOE4 sequencing is NOT DIAGONSTIC*** → despite high association with AD, E4 does not guarantee AD
Not sensitivity or predictive for late onset AD
Low Negative predictive value for AD: >50% of AD patient has no E4 allele
So testing negative for E4 doesn’t mean you're not going to develop AD
Incomplete PPV for AD: most people with 1 E4 allele do not develop AD
Unclear clinical benefit to knowing ApoE status: knowing may not improve outcome and may cause psychological stress
Alizhimer’s Disease: Potential Preventive+Treatment Strategies
Potential:
Amyloid “vaccine”
Tau inhibitors
Statins (lipid lowering)
****The MIND DIET*** (Mediterranean based diet)
50% risk reduction over 10 years
35% risk reduction over 10 years w/ even moderate adherence
Treatments
Acetylcholenesterase inhibitor: temporarily improve memory but not progression
Amyloid Target therapies: Amyloid antibodies + amyloid plaque removers
Parkinson’s Diesases: Basic info
2nd most common Neurodegenerative Disorder
1st most common Neurodegenerative MOVEMENT Disorder
Lifetime Risk
1.5%
Age of Onset
Average: 40-70yo
Juvenile Onset (JO): less than 20yo
Early Onset (EO): 20-40yo
Adult Onset (AO): over 40yo
Median Survival
10-15 years from diagnosis
Parkinson’s Disease: Overview
Genes: Many genes w different inheritance - progressive loss of DOPAaminergic neurons
LRRK2 (most common for AO), SNCA (rare but penetrant, EO)
PARK2 (most common for JO), PINK1 (EO), PARK7 (EO)
Inheritance
Autosomal Dominant: LRRK2, SNCA
Autosomal Recessive: PARK2, PINK1, PARK7
10% Inherited Parkinsons disease
90% Sporadic Parkinsons disease
Clinical Features
Bradykinesia: slowing of movement
Resting Tremor:
Rigidity
Gait Ataxia
Minor features:
Constipation, Cognitive impairment, dementia, depression, Micrographia (small handwriting)
Pathology
Presence of Lewy Bodies → BUT, not unique to Parkison’s
Loss of DOPAmingeic neurons
Diagnosis
MADE CLINICALLY NOT VIA GENETIC TESTING
Treatment
Primarily dopamine replacement → L-DOPA
Overlap of Parkinson and Other Diease
1st Degree
Lewy Body Dementia
Alzheimer’s Disease
Wilsons disease
Dopa-responsive dystonia
2nd Degree
Drug induced
Toxic exposures
Dementia Pugilistica
Parkinson’s Disease: Genes and who to Test
PARKIN: Juvenile Onset (<20yo) - Very slow progression,
Recessive
No Lewy bodies
No Dementia
80-90% of JO Parkinson
10-50% of EO Parkinson
SNCA: Early onset (20-40yo) - Typical progression,
Dominant
YES Lewey Bodies
Yes Dementia (sometimes)
LRRK2: Adult onset (>40yo) - typical progression
Dominant
NO Lewey bodies
No dementia
*****INCOMPLETE PENETRANCE: only 30% w/ LRRK2 mutation develop Parkinson*****
Good DOPA response
****FOUNDER MUTATIONS: Higher rates of mutation in Ashkenazi + North Africa****
Huntington Disease: Overview
Gene: HTT (protein important for neuron health)
CAG repeats create a long glutamine tract in the HTT protein→ causes gain-of-function activity which leads to neuronal dysfunction
Normal function: <26 repeats
Intermediate: 27-35 repeats → normal function, but risk for expansion - “Anticipation Zone”
Reduced Penetrance: 36-39 repeats
Complete Penetrance, Pathogenic: >40 repeats
Juvenile: >60 repeats
Inheritance
Autosomal Dominant
Variable Penetrance
Anticipation can occur:
ESPECIALLY DURING SPERMOGENESIS → Paternal Transmission VERY COMMON
Clinical Features
Average age of onset 35-44yo; Progression over 10years; Death 15-20 yrs after symptom onset
Chorea: involuntary movement (“dance-like”)
Mood/Personality changes: depression, irritability, OCD
Cognitive decline: executive dysfunction, slowed processing, dementia
Juvenile form: 5-10% of HD, Onset before 20yo
Also includes: Rigidity, Seizures, Developmental Regression
Treatment
currently NO TREATMENTS to alter the course of the disease
Huntington’s Disease: Genetic Testing
HD can be highly penetrant for >40 CAG repeat - very specific Genetic testing protocol is recommended for Asymptomatic at-risk adults
Active Psychiatric problems must be stabilized before testing
Local counselor should be identified
Support person who is NOT at risk for HD should accompany patient
Testing Minors for Adult-Onset Huntington Disease is not generally recommended UNLESS there is a direct medical benefit (i.e. patient has Juvenile onset symptoms)
Testing Process
Initial Telephone contact: inform patient of process
Visit #1: Genetic Counseling, Informed consent
Mental Health assessment during session: make sure they can handle it
Visit #2: Disclose results, arrange follow-up
Follow up
Spinocerebellar Ataxias
Dozens of types
All are Trinucleotide Repeat Disorders
All are Autosomal Dominant (+FamHx)
Present with various degrees of difficulty with:
Gait
Balance
Speech
Fine motor skills
Friedreich’s Ataxia
Gene: FXN (important Mitochondrial gene → mitochondrial disease profile: cardiomyopathy, impacts on brain)
GAA repeats cause protein dysfunction
Normal: <33 Repeats
Premutation: 34-65 repeats
Reduced Penetrance: 44-66 repeats
Pathogenic: >66 repeats
Inheritance
Autosomal Recessive
96% w/ symptoms: two FXN copies with ‘disease repeats’
4% w/ symptoms: one allele has normal repats but a pathogenic variant → NEED TO DO DEL/DUP ANAYLSIS
Clinical Features
Age of onset 5-15yo
Ataxia: especially limb movement (Falls)
****Absent Ankle Reflexes***** (Feet)
Hypertrophic cardiomyopathy (Heart)
Diabetes (Sugar)
Skeletal finding
PES CAVUS
Scoliosis
“Fred is FXN to have Feet Falls and Sugar Heart.”
Amyotrophic Lateral Sclerosis (ALS)
Gene: only 10% inherited (familial) while 90% sporadic (simplex)
C9orf72 (Most common) 30-40% of FALS: a repeat expansion w/ ***frontotemporal dementia***
SOD1: 15-20% of FALS
FUS: 3-5% of FALS: younger onset and more aggressive
TARDBP: 2-5% of FALS
Inheritance
Autosomal Dominant
SOD1 can be autosomal recessive
Clinical Features
Age of onset 40-60yo
****NORMAL SENSATIONS****
motor neurons affects NOT sensory neurons
Lower Neuron degeneration
Muscle weakness
Muscle wasting
Decreased reflexes
Upper neuron degeneration
Hyperflexia (reflexes respond too strongly)
Spasticity
Babinksi sign (abnormal reflex of big toe)
*****Frontotemporal Dementia***** (not all genes)
ALS historically thought to not affect cognition, but some genes overlap with FTD
Treatment
historically supportive, but now there are diease slowing drugs
Myopathy
Any disease of muscle and can present with:
Muscle weakness
Muscle Pain
Low muscle tone (hypotonia)
Can be congenital (at birth) or later in life
Skeletal muscle affected → diminished strength, inflammation and muscle loss
Proximal muscles (Large muscle groups that attach to the trunk - shoulders, back, hips) more affected than Distal muscles (lower arms, hands, legs, feet) - hard to stand or raise muscle over head
Often Cardiac Muscle affect → CARDIOMYOPATHY
Myopathy: Suggestive Tests
Serum CPK and/or Aldolase: usually within the muscle, but when muscle is destroyed it is release
non-specific for congenital myopathies
Electromyography (EMG)/Nerve Conduction Velocity(NCV)
“myopathic” Pattern, NCV normal
Muscle Biopsy
show destroyed muscle cells
indicate missing muscle protein
Neuropathy
Disorder of peripheral nerves and also present with
Weakness
Pain (more pins and needles and shooting pain than deep muscle pain)
Sensation: decreased or hyperactive
Depends on Nerves Affected:
Motor Nerves: Decreased strength w/ Pain
usually the DISTAL (like hands and feet) muscle rather than proximal (myopathy)
Sensory Nerves: Decreased Sensation, Paresthesia
Autonomic Nerves: Multisystem involuntary dysfunctions
Cardiac: Intolerance of standing/changing position → palpations + passing out
GI: Slowed movement of bowels → constipation
Skin: Sweat/Temperature dysregualtion
Neuropathy Suggestive Tests
Electromyography(EMG)/Nerve Conduction Velocity (NCV)
“Neuropathic” slowing of NCV
Sudoscan (Low Voltage Sweat Gland Activation)
Abnormal with small fiber and autonomic neuropathies
Nerve Biopsy
Congenital Hypotonia
Low tone in babies: “Floppy” Newborn
Tone= the involuntary positioning in the body
strength = involuntary muscle activity
Prader-Willi Syndrome
Profound Hypotonia: MAGEL2 gene associated
the 5 H’s
hypotonia
Hyperphagia
Hypomania
Hypopigmentation
Hypogonadism
Chromosome 15q11-13 microdeletion or paternal methylation defect
Myotonic Dystrophy 1
Gene: DMPK (a protein expressed in muscles)
“CTG" repeats in the untranslated region of DMPK gene → create RNA that disrupts a large number of other genes (THE RNA IS “TOXIC” not the DMPK PROTIEN)
Normal: <35 repeats
Premutation: 35-49 repeats
Mild: 50-150 repeats
Classic: 100-1000 repeats
Congenital: >1000 repeats
Inheritance
Autosomal Dominant
Passed on more through ***MATERNAL TRANSIMSSION***
***Maternal meiosis more susceptible to EXPANSION***
Clinical Features
Mild Form: Adult Onset: 20-70yo
Mild Myotonia (unable to release, unclench fist)
Cataracts
Classical Form: Adult/childhood Onset : 10-30yo
Myotonia
Muscle Weakness
Distal muscles first: hand weakness, foot drop, facial weakness
Then proximal weakness
Cataracts
Cardiac Arrythmia
Diabetes
**Baldness**
****Congenital Form: ONLY COMES FROM MOTHER (but mother doesn’t need to affected: ANTCIPATION IS VERY STRONG)***
Present at Birth w/ Early death
Profound congenital hypotonia
Respiratory deficits
Intellectual disability
Reflexes are intact
Treatments
Multiple in clincial trials
Muscular Dystrophies
Highly heterogenous
But some are simple and monogenic like Duchenne/Becker Muscular dystrophy
Duchenne/Becker Muscular Dystrophies: Overview
Gene: DMD (codes for dystrophin, a structural protein important for muscle fiber contraction)
Exon Deletions (60-70%) - ***ALWAYS START WITH DEL/DUP ANALYSIS***
Duplication (10%)
Sequence variants (20-30%)
Inheritance
X-Linked Recessive
2/3 Inherited (from carrier mother)
1/3 Sporadic
Clinical Features
Duchene: disruption occurs OUT of reading frame/ is LARGER → fully nonfunctional protein → SEVERE w EARLIER ONSET
Becker: Disruption occurs IN frame / smaller deletion → partially functional protein → Less Severe with later onset
Duchenne Muscular Dystrophy - Clinical presentation
Age of Onset 3-5 years old
Proximal Muscle Weakness
Gower Maneuver: using arms to stand up
Wheelchair dependent in 2nd decade
Death by 3rd decade - Respiratory or cardiac failure
***Dilated Cardiomyopathy***
****Calf pseudohypertrophy****: enlargement of calves due to fibrofatty replacement of muscle
Cognitive Affect: Learning disabilities, ADHD, Autism
Tests
Elevated CK Levels (10-100x normal) and Adolase levels
****Absent/extremely low DYSTROPHIN on muscle biopsy***
Female carriers are asymptomatic but might develop: Cardiomyopathy, mild weakness, elevated CK
Becker Muscular Dystrophy - Clinical Presentation
Age of onset variable but later than Duchenne (<16yo, 20s, Adulthood) - Death in mid40s yo
Slower Progression
Preserved ambulation much longer → ***but still lost eventually***
Variable weakness
****DIALTED CARDIOMYOPATHY CAN STILL BE SEVERE****
***Calf Pseudohypertrophy Present***
MAJOR DIFERENCE FROM DMD: Preservation of the NECK FLEXOR MUSCLE
Tests
Elevated CK and Aldolase, but not as much as Duchenne
****Dystrophin Protein present on Muscle Biopsy****
Duchenne/Becker Dystrophy Management
Monitoring
Cardiac
Female DMD carriers are still at risk for DCM
Respiratory
Overall Strength
Supportive
Physical Therapy
Cardio/respiratory support (vent/trach)
Treatment/Preventative
cortical steroids - Give in early childhood slow progress of diease
Variant specific medications →
NBS for DMD/BMD efficacy being studied: early drug interventions show promise to slow progression of diease
Facioscapulohumeral Muscular Dystrophy (FSHD): Overview
Gene: DUX4 (an embryonic development gene that should be OFF in adults), SMCHD1 (epigenetic regulator of DUX4)
DELETION of D4Z4 repeats on chr. 4q35 → DUX4 ON (95%)
normal: 11-100 D4Z4 repeats
FSDH: 1-10 D4Z4 repeats
SMCHD1 pathogenic variant = no methylation of D4Z4 region → DUX4 On (5%)
Inheritance
Autosomal Dominant
2/3 Inherited
1/3 De Novo
Clinical Features
Age of onset early 20s, SLOW head-to-toe PROGRESSION, ***Asymmetric*** → NORMAL LIFE EXPECTANCY
Facial muscles
Shoulder + upper arm muscles
Lower extremities mainly foot dorsiflexors
20% of patients: Hip + Abdominal muscle → leads to loss of ambulation
REFLEXES PRESERVED
Other features:
Sensio-neural Hearing loss (60%)
Atrial Arrythmia
Mild Creatine Kinase elevation
Spinocerebellar Ataxia (SCA)
Gene: ATXN1, ATXN7
“CAG” repeats in AXTN genes = toxic gain-of-function activity
Normal </= 35 CAG repeats
Reduced penetrance (RARE) 36-38 CAG repeats
Full Penetrance >/= 39 CAG repeats
Inheritance
Autosomal Dominant
****Paternal Transmission DRAMATICALLY increased Anticipation****
Especially for ATXN7
Can result in parent having an SEVERLY affect child: childhood onset, sever diease, rapid progression
Clinical Features
Age of Onset 30-40, Progressive, Life shortening ( 15-25 years after symptom onset)
Cerebellar Ataxia
Gait Instability
Poor hand-eye coordination, eye movements
Slurred Speech
****FOR ATXN7 ONLY: Retinal Degeneration******
Genetic Testing
Spinal Muscular Atrophy (SMA)
Gene: SMN1 (important for spinal cord neurons)
Deletion of exon 7 of SMN1 in BOTH COPIES = loss of function (95%)
Deletion in one SMN1 copy + sequence variant on the other = loss-of function (5%)
***SMN2**** gene: disease modifier → more copies = more SMN protein = MILDER DIEASE
Inheritance
Autosomal Recessive
****1:50 carrier frequency****
Clinical Features
Variable onset: SMN2 copies modify - prenatal to adulthood
Hypotonia
Progressive Skeletal and Respiratory muscle weakness
****Absent Reflexes****
Normal Sensation
Normal intelligence
Treatment
Early treatment crucial: before symptoms develop → IDENTIFED VIA NBS
Drugs prevent loss of exon 7 in SMN1 = preserved function
Normal milestones and life expectancy
Hereditary Neuropathy
Charcot-Marie tooth (CMT) type 1A
Gene: PMP22 (stabilizes myelin + maintains peripheral nerve function)
1.4 MB DUPLICATION → extra copy of PMP22 = slowed nerve conduction
****START WITH DEL/DUP ANALYSIS****
Inheritance
Autosomal Dominant
90% Inherited
10% De Novo
Clinical Features
Average age of onset 10-20yo, slowly progressive start with FEET+LOWER LEGS
Neuropathic Pain
Distal muscle atrophy (legs)
Weakness in Hands + Feet
*INVERTED WINE BOTTLE LEGS*
*****PES CAVUS***** (high arched feet)
Absent reflexes
Loss of Sensation
Normal Life expectancy
Testing
Hereditary neuropathy with liability to pressure palsies (HNPP)
PMP22 (stabilizes myelin + maintains peripheral nerve function)
1.4 MB DELETION→ loss of a copy of PMP22 = slowed nerve conduction [SAME REGION AS Charcot-Marie tooth]
****START WITH DEL/DUP ANALYSIS***
Pressure that normal people could easily tolerate causes NERVE DAMAGE in HNPP patients
Inheritance
Autosomal Dominant
80% inherited
20% De Novo
Clinical Features
Age of onset teen to 20syo, Normal Lifespan
Recurrent Focal Neuropathies (weakness, numbness and pain from nerve damage)
Foot (causes FOOT DROP) → crossing legs, squatting, kneeling
Elbow
Wrist → Carpal Tunnel syndrome
Cognition Normal
Emery–Dreifuss Muscular Dystrophy (EDMD)
Gene: EMD, LMNA (important for muscle cell ability to take mechanical stress)
Inheritance
Variable
X-Linked : EMD
Autosomal Dominant: LMNA
Clinical Features
Age of onset 10yo, Normal cognition
****Contractures****: inability to STRAIGHTEN a joint
Elbow*
Neck
Heels*
Muscle Weakness (progressive, after contracture)
Shoulders
Upper Arms
Calves
****Cardiomyopathy****
Conduction defects
May cause FAINTING
Sudden cardiac death a risk
Normal Creatine Kinase level
Limb-Girdle Muscular Dystrophy (LGMD)
Gene: 30 genes; Many forms
Inheritance
Type 1: Autosomal Dominant
Type 2: Autosomal Recessive
Clinical Features
Onset variable: childhood to adulthood; Progressive, ***Symmetrical***
Limb-Girdle muscle weakness- proximal muscles around hips and shoulder
Pelvic girdle: hips, butt, thighs
Shoulder girdle: shoulders, upper arms
****Creates “Waddling Gait”****
Cardiomyopathy: depending on the form
Sensation Normal
Cognition Normal
***Elevated Creatine Kinase***
Trinucleotide Repeat Disorders
Huntingtons Diease (CAG)
Spinocerebellar ataxia (CAG)
Friedreich’s ataxia (GAA)
Fragile X Syndrome (CGG)
Myoyonic dystrophy (CTG)